Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

UNKNOWN × Temozolomide × CNS × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Unknown 1 Completed 1

Sponsor Class

OTHER 397 INDUSTRY 122 NIH 59 NETWORK 37 UNKNOWN 2 OTHER_GOV 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2 Sarcoma 1 NET 1 Gastrointestinal 1 Endocrine 1

Conditions

Brain Neoplasms 2 Meningeal Carcinomatosis 1

Interventions

Radiotherapy, Intensity-Modulated 3 Temozolomide 2 pyrotinib 1 Vinorelbine 1 Radiation Dose Hypofractionation 1 Pharmaceutical Preparations 1 Gefitinib 1 Erlotinib Hydrochloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03778541 2019-07-23

HFSRT With Concurrent TMZ for Large BMs

ChineseAMS

Phase 3 Unknown

Brain Neoplasms

NCT02654106 2017-06-06

SRTRBM

ChineseAMS

Phase 2 Completed

Brain Neoplasms, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡